ProteoSil 200-C8, UHPLC PEEK Analytical Column 3um, 2.1x100mm HPLC Column

The ProteoSil 200-C8 HPLC column 100x2.1mm, 3µm, is a C8-modified phase with a pore size of 200 Å. The ProteoSil 200-C8 was developed for medium-sized peptides, oligonucleotides, and smaller proteins in the range from a few kDa to several tens of kDa. Compared to C18 phases, the hydrophobic interaction is weaker, allowing highly retained analytes to elute more quickly. At the same time, clear reverse-phase selectivity is maintained. Typical applications include peptide and oligonucleotide methods where retention on a C18 phase is too high or where alternative selectivity is required for method development.

Features and Benefits

• Bio-LC column series for proteins, peptides, oligonucleotides, nucleic acids, and biopharmaceutical applications
• High-purity silica with controlled pore sizes of 100 Å, 200 Å, and 300 Å
• Choice between reverse-phase, HILIC, and size-exclusion chromatography
• Stainless steel, PEEK, and bio-inert hardware for various requirements
• Low lot-to-lot variability and consistent quality, even for LC/MS methods

Additional Information

The ProteoSil series is designed for bioseparations in which pore size, modification, and hardware must be specifically tailored to sensitive biomolecules. It is based on a high-purity silica matrix with pore sizes of 100 Å, 200 Å, or 300 Å. Smaller pores are particularly suitable for low-molecular-weight peptides, while 200 Å materials are used for medium-sized peptides and oligonucleotides. For larger proteins, hydrophobic peptides, and antibodies, 300 Å materials are available. In addition, ProteoSil HILIC and ProteoSil SEC round out the series for hydrophilic analytes and size-based separations. Using appropriate ProteoSil pre-column cartridges or guard columns, the analytical column can be protected from particles, strongly adsorbing sample components, and matrix carryover.

Legal Information

ProteoSil is a registered trademark of the manufacturer GL Sciences Inc., Tokyo, Japan.